Meflochina ed ototossicità: Descrizione di tre casi

Clinica Terapeutica

Volumn 150, Issue 5, 1999, Pages 379-382

  Fusetti, Marco ^a   Eibenstein, A ^a   Corridore, V ^a   Hueck, S ^a   Chiti Batelli, S ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Malaria prophylaxis; Ototoxicity

Indexed keywords

MEFLOQUINE; ANTIMALARIAL AGENT;

ARTICLE; AUDIOLOGY; CASE REPORT; HUMAN; MALARIA; OTOTOXICITY; PERCEPTION DEAFNESS; PROPHYLAXIS; TINNITUS; ACOUSTIC IMPEDANCE; CHEMICALLY INDUCED DISORDER; FEMALE; HEARING LOSS; MALE; PURE TONE AUDIOMETRY; REVIEW; TIME;

ACOUSTIC IMPEDANCE TESTS; ANTIMALARIALS; AUDIOMETRY, PURE-TONE; FEMALE; HEARING LOSS, HIGH-FREQUENCY; HUMANS; MALARIA; MALE; MEFLOQUINE; TIME FACTORS; TINNITUS;

EID: 0033398556     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. White NJ, Ho M: The pathophisiology of malaria. Adv Parasitol 31: 83-172, 1992
2. Behrens RH, Curtis CF: Malaria in travellers: epidemiology and prevention. Br Med Bull 49: 363-381, 1993
3. Bradley DJ, Warhurst DC: Malaria Prophylaxis: guidelines for travellers from Britain. Malaria Reference Laboratory of the Public Healt Laboratory Service, London. BMJ 310: 709-714, 1995
4. Lobel O, Miani M, Eng T: Long-term malaria prophylaxis with weekly mefioquine. Lancet 341: 848-851, 1993
5. Schlagenhauf P, Steffen R: Stand-by treatment of malaria in travellers: a review. J Trop Medllyg 97:151-160, 1994
6. Karbwang J, Bangchang K: Clinical Pharmacokinetics of mefloquine. Clin Pharmacokinet 27: 104-119, 1990
7. Luxemburger C, Price RN, Nosten F: Mefloquine in infants and young children. Ann Trop Paediatr 16: 281-286, 1996
8. Schlagenhauf P, Steffen R'Loebel II: Mefloquine tolerability during chemoprophylaxis: focus on adverse event assesments, stereochemistry and compliance. Trop Med Int Healt 1: 485-494, 1996
9. Steffen R, Fuchs E, Schildchnect J: Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Mrica. Lancet 341:1299-303, 1993
10. Boudreau E, Schuster B, Sanchez J: Tolerability of prophilactic Lariam regimen. Trop Med Parasistol 44:257-265, 1996
11. Brown RD, Feldman AM: Pharmacology of hearing and ototoxicity. Ann Rev Pharmacol Toxicol 18: 233-252, 1978
12. Phillips-Howard PA, Kuile FO: CNS adverse events associated with antimalarial agents. Fact or fiction? Drug Saf; 12: 370-383, 1995
13. Boston Collaborative Drug Surveillance Program: Drug induced deafness. JAMA 224: 515-516, 1973
14. Barret PJ, Emmins PD, Clarke PD: Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers. Medical Advisory Services for Travellers Abroad, London BMJ 313: 525-8, 1996
15. Kuile FO, Nosten F, Thieren M: High dose mefloquine in the treatment of multidrug resistant falciparum malaria. J Infect Dis 166: 1044-1049, 1992
16. Kuile FO, Nosten F, Luxemburger C: Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients. Bull World Healt Organ 73: 631-642, 1995
17. Alvan G, Karlsson KK, Villén T: Reversible hearing impairment related to quinine blood concentrations in guinea pigs. Life Sci 45: 751-755, 1989
18. Mvan G, Karlsson KK, Hellgren U, Villén T: Hearing impairment related to plasma quinine concentration in healthy volunteers. Br J Clin Pharmacol 31: 409-412, 1991
19. Davis TM, Dembo LG, Kaye-Eddie SA: Neurological, cardiovascular and metabolic effects of mefloquine in healty volunteers: a double blind, placebo controlled trial. Br J Clin Pharmacol 42: 415-421, 1996
20. Ohrt C, Richie TL, Widjaja H: Mefoquine compared with Doxycycline for the prophylaxis of malaria in Indonesian soldiers. Ann Intern Med 126: 963-972, 1997
21. Tange RA, Dreschler WA, Claessen FA: Ototoxic reactions of quinine in healty persons and patients with Plasmodium falciparum infection. Auris Nasus Larynx 24: 131-136, 1997
22. Bateman DN, Dyson EH: Quinine toxicity. Adverse Drug React Acute Poisoning Rev 5: 215-233, 1986
23. Nguyen Thi Hoang Mai, Day NPJ, Waller D: Post-malaria neurological syndrome. Lancet 348: 917-921, 1996
24. Paintaud G, Mvan G, Berninger E, et al.: The concentration-effect relationship of quinine-induced hearing impairment. Clin Pharmacol Ther 55: 317-323, 1994
25. Karlsson KK, Flock A: Quinine causes isolated outer hair cells to chenge lenght. Neurosci 116: 101-105, 1990 (letter)
26. Karlsson KK, Berninger E, Gustavsson L et al.: Pronounced quinine-induced cochlear hearing bss. A mechanistic study in one volunteer at multiple stable plasma concentrations. J Aud Med 4: 12-24, 1995